Edward B. Perkins MD

Hematologic Oncology

Assistant Professor, Internal Medicine, Virginia Commonwealth University, Medical College of Virginia School of Medicine

Join to view full profile

1250 E Marshall StRichmond, VA 23298

Dr. Perkins is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Perkins' full profile Already have an account?

Education & Training

Virginia Commonwealth University Health SystemFellowship, Hematology and Medical Oncology, 1999 - 2002
Virginia Commonwealth University Health SystemResidency, Internal Medicine, 1996 - 1999
Virginia Commonwealth University School of MedicineClass of 1996

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

VA State Medical License 1997 - 2024

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Cerner Millennium Powerchart, Cerner Millennium FirstNet, Cerner Millennium ProFile, Health Sentry, Healthe Exchange, Cerner Healthe Record, IQHealth and P2 Sentinel (Powered by Sensage), Cerner Corporation, 2013-2015
CMS Meaningful Use Stage 1 Certification PowerChart, FirstNet, HealthSentry and P2 Sentinel, Cerner Corporation, 2013-2015

Publications & Presentations

PubMed

17 citations
Phase I Trial of Bortezomib (PS-341; NSC 681239) and “Nonhybrid” (Bolus) Infusion Schedule of Alvocidib (Flavopiridol; NSC 649890) in Patients with Recurrent or Refrac...
Beata Holkova, Maciej Kmieciak, E. Brent Perkins, Prithviraj Bose, Rachid Baz
Clinical Cancer Research. 2014-11-15
28 citations
A phase I trial of vorinostat and alvocidib in patients with relapsed, refractory, or poor prognosis acute leukemia, or refractory anemia with excess blasts-2.
Beata Holkova, Jeffrey G. Supko, Matthew M. Ames, Joel M. Reid, Geoffrey I. Shapiro
Clinical Cancer Research. 2013-04-01
17 citations
Phase I Trial of the Combination of Flavopiridol and Imatinib Mesylate in Patients with Bcr-Abl+ Hematological Malignancies
Prithviraj Bose, Edward B. Perkins, Connie Honeycut, Martha D. Wellons, Tammy Stefan
Cancer Chemotherapy and Pharmacology. 2012-02-15